# Verdezyne

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/verdezyne

- Industry: Biotechnology
- Headquarters: Carlsbad, US
- Website: www.verdezyne.com
- Total disclosed funding: $7M
- Latest round: Series C (May 9, 2007)
- Investors on record: 4

## About

Verdezyne, Inc. focuses on developing sustainable biochemical solutions to transform the production of everyday products, utilizing innovative microbial technologies to create renewable and environmentally friendly alternatives.Founded in 2005 and headquartered in Carlsbad, US, Verdezyne, Inc. specializes in bioengineering platforms for producing various chemicals. The company has undergone significant growth, securing USD 48.00 mn in funding from Sime Darby Berhad and other investors, primarily for advancing its biotechnological innovations. The firm's latest funding round occurred in April 2014, representing the total amount raised thus far.Verdezyne, Inc. specializes in developing innovative biochemical solutions aimed at replacing petroleum-based products. The company’s primary offerings include microbial production processes for sustainable chemicals, targeting industries such as plastics, textiles, and consumer goods. Through its proprietary technology, Verdezyne enables the creation of renewable alternatives, thus supporting businesses in their transition towards sustainability.Verdezyne, Inc. operates a revenue model based on contracts with industry partners that engage in sustainable production methods. The company has established agreements with various sectors to provide biochemical solutions that meet their production needs, with pricing structures reflecting the value of sustainable sourcing and innovation. Transactions are typically executed via direct agreements, fostering stable revenue streams for ongoing operations.Verdezyne, Inc. aims to expand its product offering with new microbial technologies anticipated for launch in the coming years. The company plans to target additional markets in Europe and Asia by 2025, leveraging its recent funding of USD 48.00 mn from the April 2014 investment round. This funding will support research and development initiatives, enabling Verdezyne to enhance its competitive position in the sustainable chemical sector.

## Funding rounds

- Series C, May 9, 2007, $7M — OVP Venture Partners, Monitor Ventures, Seraphim Space Manager, Tech Coast Angels

## Investors

- OVP Venture Partners (https://capitalatlas.ai/funds/ovp-venture-partners) — Series C
- Monitor Ventures (https://capitalatlas.ai/funds/monitor-ventures) — Series C
- Seraphim Space Manager (https://capitalatlas.ai/funds/seraphim-space-manager) — Series C
- Tech Coast Angels — Series C